Click here for slides on this topic


Kidney disease

See also Nephropathy.
The following content matched the glossary term: Kidney disease

Endocrine Society Guideline on Diabetes and Pregnancy - Glycemic Targets & Glucose Management

Top

Diabetes Management Guidelines Endocrine Society Guideline on Diabetes and Pregnancy   Source Blumer I, Hadar E, Hadden DR, et al. Diabetes and pregnancy an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013 98(11) 4227 4249. Available here.Refer to

Impact of specific glucose-control strategies on microvascular and macrovascular outcomes in 58,000 adults with type 2 diabetes

Top

Neugebauer R, Fireman B, Roy JA, O’Connor PJ. Impact of specific glucose-control strategies on microvascular and macrovascular outcomes in 58,000 adults with type 2 diabetes. Diabetes Care. 2013;36:3510-3516.

Changes in diabetes-related complications in the United States, 1990–2010

Top

Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med. 2014;370:1514-1523.

American Diabetes Association (ADA) Nutrition Guidelines for Adults With Diabetes

Top

Diabetes management guidelines for nutrition from the American Diabetes Association (ADA)

Treating the Patient With Type 2 Diabetes and Renal Impairment – References

Top

Patient case: 58-Year-Old African-American Woman with Type 2 Diabetes, Worsening Kidney Function, and Cardiometabolic Comorbidities  

Presented by NDEI Education Council Member, Vivian A. Fonseca, MD

 

Treating the Patient With Type 2 Diabetes and Renal Impairment – Key Take-Home Messages

Top

Patient case: 58-Year-Old African-American Woman with Type 2 Diabetes, Worsening Kidney Function, and Cardiometabolic Comorbidities

Presented by NDEI Education Council Member, Vivian A. Fonseca, MD

 

Treating the Patient With Type 2 Diabetes and Renal Impairment – Follow-Up Pharmacologic Therapy Considerations Proteinuria

Top

Patient case: 58-Year-Old African-American Woman with Type 2 Diabetes, Worsening Kidney Function, and Cardiometabolic Comorbidities  

Presented by NDEI Education Council Member, Vivian A. Fonseca, MD

 

Treating the Patient With Type 2 Diabetes and Renal Impairment – Follow-Up Pharmacologic Therapy Considerations Metformin

Top

Patient case: 58-Year-Old African-American Woman with Type 2 Diabetes, Worsening Kidney Function, and Cardiometabolic Comorbidities  

Presented by NDEI Education Council Member, Vivian A. Fonseca, MD

 

Treating the Patient With Type 2 Diabetes and Renal Impairment – Follow-Up

Top

Patient case: 58-Year-Old African-American Woman with Type 2 Diabetes, Worsening Kidney Function, and Cardiometabolic Comorbidities  

Presented by NDEI Education Council Member, Vivian A. Fonseca, MD

 

1 2 3 4 5 6 Next 

Slide Library Results

Search Results for: Kidney disease Slides Found: 40
Compelling Indications for Hypertension Drug Classes
RENAAL: Impact of Losartan in Chronic Kidney Disease
ISHIB Recommendations for African-Americans With High BP
Recommended Treatment of Hypertension in Diabetes
Compelling Indications for Hypertension Drug Classes (1 of 2)
Kidney Disease and Diabetes
Medical Comorbidities Associated with Obesity
ADA/AGS 2012 Consensus Report on Diabetes in Older Adults: Considerations for Glycemia, BP, and Dyslipidemia
ADA/AGS 2012 Consensus Report on Diabetes in Older Adults: Recommendations for Care and Treatment (2 of 3)
ESH/ESC Hypertension Guidelines: CV Risk Stratification
ESH/ESC Hypertension Guidelines: Medical History
ESH/ESC Hypertension Guidelines: Lifestyle, Antihypertensive Therapy for High Normal BP
ESH/ESC Hypertension Guidelines: Lifestyle, Antihypertensive Therapy for Grade 1 HTN
ESH/ESC Hypertension Guidelines: Lifestyle, Antihypertensive Therapy for Grade 2 HTN
ESH/ESC Hypertension Guidelines: Lifestyle, Antihypertensive Therapy for Grade 3 HTN
ESH/ESC Hypertension Guidelines: BP Goals for Hypertensive Patients
nbESH/ESC Hypertension Guidelines: Hypertension Treatment for Patients With Nephropathy
ALTITUDE: No Reduction in CV, Renal Events with Aliskiren
ALTITUDE: Increased Hyperkalemia, Renal Impairment with Aliskiren
ADA Nutrition Guidelines: Protein
IDF Type 2 Diabetes Guidelines Kidney Disease | NDEI
BP Treatment Goal for Adults With CKD JNC 8 Guidelines PPT | NDEI
JNC 8 Hypertension Treatment Algorithm Guidelines PPT | NDEI
JNC 8 Hypertension Treatment Algorithm Adults With Diabetes or CKD | NDEI
JNC 8 Guidelines SBP Target Adults Over Age 60 PPT | NDEI
JNC 8 Implications of SBP Goal Adults Over Age 60 PPT | NDEI
JNC 8 Hypertension Guidelines 2014 PPT | NDEI
JNC 8 Guidelines Treatment Hypertension CKD PPT | NDEI
JNC 8 SBP Goal Older Adults Disagreement PPT | NDEI
ADA EASD Type 2 Diabetes Treatment Hyperglycemia PPT | NDEI
Blood Pressure Targets Type 2 Diabetes AHA ADA Guidelines | NDEI
Kidney Disease in Type 2 Diabetes for CVD Prevention PPT | NDEI
Diabetic Kidney Disease Screening & Treatment ADA Guidelines | NDEI PPT
Managing Diabetic Kidney Disease ADA Guidelines 2016 | NDEI PPT
Managing Dyslipidemia During Pregnancy NLA Cholesterol Guidelines | CCMD
NLA Cholesterol Guidelines High or Very-High ASCVD Risk | CCMD
Very-High ASCVD Risk LDL Goals NLA Cholesterol Guidelines | CCMD
LDL-C Target for High ASCVD Risk NLA Cholesterol Guidelines | CCMD
Empagliflozin Reduces Kidney Disease in EMPA-REG OUTCOME CVOT | NDEI
Empagliflozin Renal Outcomes in EMPA-REG OUTCOME CVOT | NDEI